Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2025)

Fennec Pharmaceuticals' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.75 for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 18.59% year-over-year to 0.75, compared with a TTM value of 0.75 through Dec 2025, down 18.59%, and an annual FY2025 reading of 0.77, down 41.61% over the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.75 at Fennec Pharmaceuticals, down from 0.82 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.94 in Q1 2024, with the low at 0.04 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.42, with a median of 0.54 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio plummeted 350.13% in 2022 and then skyrocketed 4380.41% in 2023.
  • Tracing FENC's Asset Utilization Ratio over 5 years: stood at 0.01 in 2021, then crashed by 896.63% to 0.04 in 2022, then surged by 2366.74% to 0.91 in 2023, then increased by 0.88% to 0.92 in 2024, then fell by 18.59% to 0.75 in 2025.
  • Per Business Quant, the three most recent readings for FENC's Asset Utilization Ratio are 0.75 (Q4 2025), 0.82 (Q3 2025), and 0.73 (Q2 2025).